A2AR Expression and Immunosuppressive Environment Independent of
A2AR
CD39
CD73
PDL-1
pseudomyxoma peritonei
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
20 Jul 2023
20 Jul 2023
Historique:
received:
25
05
2023
revised:
07
07
2023
accepted:
18
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
In pseudomyxoma peritonei (PMP),
Identifiants
pubmed: 37509688
pii: biomedicines11072049
doi: 10.3390/biomedicines11072049
pmc: PMC10377259
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Italian Association for Cancer Research
ID : AIRC IG 2016 Id.19206
Références
Cancer Discov. 2016 Mar;6(3):256-69
pubmed: 26715642
Cancer Cell. 2005 May;7(5):411-23
pubmed: 15894262
Sci Signal. 2016 May 31;9(430):ra56
pubmed: 27245613
PLoS One. 2013 Sep 06;8(9):e73616
pubmed: 24040001
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Nat Rev Immunol. 2016 Mar;16(3):177-92
pubmed: 26922909
PLoS One. 2017 Jun 22;12(6):e0179510
pubmed: 28640835
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13132-7
pubmed: 16916931
Int J Mol Sci. 2018 Dec 02;19(12):
pubmed: 30513816
J Cancer Res Clin Oncol. 2018 Jul;144(7):1253-1263
pubmed: 29725763
Immunotherapy. 2017 Mar;9(4):347-360
pubmed: 28303764
J Pathol Clin Res. 2019 Oct;5(4):217-226
pubmed: 31136102
J Immunother Cancer. 2022 Feb;10(2):
pubmed: 35135866
Eur J Surg Oncol. 2022 Jul;48(7):1590-1597
pubmed: 35090796
Clin Cancer Res. 2018 Jun 15;24(12):2859-2872
pubmed: 29602801
Surg Oncol Clin N Am. 2003 Jul;12(3):585-603
pubmed: 14567019
Ann Oncol. 2016 Nov;27(11):2097-2103
pubmed: 27502722
Lancet Oncol. 2006 Jan;7(1):69-76
pubmed: 16389186
Oncotarget. 2016 Aug 23;7(34):55828-55839
pubmed: 27331871
Front Immunol. 2019 Jul 30;10:1790
pubmed: 31417563
Nat Rev Cancer. 2017 Dec;17(12):709-724
pubmed: 29059149
Nat Rev Cancer. 2013 Dec;13(12):842-57
pubmed: 24226193
J Transl Med. 2016 May 06;14(1):125
pubmed: 27154293
Cancer. 1995 Feb 1;75(3):757-68
pubmed: 7828125
J Mol Diagn. 2018 Sep;20(5):635-642
pubmed: 29936255
Am J Clin Oncol. 2018 Aug;41(8):777-783
pubmed: 28263231
Histopathology. 2017 Dec;71(6):847-858
pubmed: 28746986
Cancer Cell. 2012 Jun 12;21(6):836-47
pubmed: 22698407
Cell Signal. 2014 May;26(5):1060-7
pubmed: 24486403
Adv Exp Med Biol. 2019;1136:113-121
pubmed: 31201720
Cell Mol Immunol. 2021 Apr;18(4):842-859
pubmed: 33139907
Oncotarget. 2017 Nov 6;8(63):106888-106900
pubmed: 29290997
Medicine (Baltimore). 2020 Jul 31;99(31):e20963
pubmed: 32756083
Curr Opin Pharmacol. 2016 Aug;29:90-6
pubmed: 27429212